What's in Kowa Company, Ltd.'s pipeline?

Kowa Company, Ltd. has 3 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Kowa Company, Ltd.'s portfolio?

Top competitors by shared drug class: Actavis Inc., Bayer, Cheng-Hsin General Hospital, Daiichi Sankyo Co., Ltd., Encube Ethicals Pvt. Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/kowa-company-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Kowa Company, Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Kowa Company, Ltd. pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
K-924 LD	K-924 LD	phase 3	Dopamine D2/D3 receptor agonist	Dopamine D2 receptor, Dopamine D3 receptor	Neurology
NIK-333(peretinoin)	NIK-333(peretinoin)	phase 3	retinoid	retinoic acid receptor	Oncology
K-924 HD	K-924 HD	phase 3	Mineralocorticoid receptor antagonist	Mineralocorticoid receptor (MR)	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Neurology · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Actavis Inc. · 1 shared drug class
Bayer · 1 shared drug class
Cheng-Hsin General Hospital · 1 shared drug class
Daiichi Sankyo Co., Ltd. · 1 shared drug class
Encube Ethicals Pvt. Ltd. · 1 shared drug class
Fougera Pharmaceuticals Inc. · 1 shared drug class
Galderma R&D · 1 shared drug class
GlaxoSmithKline · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Kowa Company, Ltd.:

Cite this brief

Drug Landscape (2026). Kowa Company, Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/kowa-company-ltd. Accessed 2026-05-16.